Oncology

Oncology

Professional Development

10 Qs

quiz-placeholder

Similar activities

Citologia maligna de mama

Citologia maligna de mama

Professional Development

11 Qs

Aortic Dissection

Aortic Dissection

Professional Development

14 Qs

INTRODUCCIÓN

INTRODUCCIÓN

Professional Development

10 Qs

Oral Mucosal Lesion & OPMD

Oral Mucosal Lesion & OPMD

Professional Development

13 Qs

Acoustic Neuroma POP Quiz

Acoustic Neuroma POP Quiz

Professional Development

10 Qs

GANGLIOS LINFÁTICOS, BAZO Y TIMO

GANGLIOS LINFÁTICOS, BAZO Y TIMO

Professional Development

10 Qs

Neoplasm Safari

Neoplasm Safari

KG - Professional Development

12 Qs

KS BP 09 Sept 2021

KS BP 09 Sept 2021

Professional Development

10 Qs

Oncology

Oncology

Assessment

Quiz

Science

Professional Development

Medium

Created by

Yee Wei Tan

Used 16+ times

FREE Resource

10 questions

Show all answers

1.

MULTIPLE SELECT QUESTION

45 sec • 1 pt

Which of the following is/are the characteristic(s) of a benign tumour?

Composed of abnormal-looking cells

Poorly differentiated

Grows very quickly

Doesn’t spread to other parts of the body

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the difference between carcinoma and leukaemia?

Carcinoma arises from epithelial tissue; leukaemia arises from bone marrow

Carcinoma arises from bone marrow; leukaemia arises from the immune system

Carcinoma arises from supporting tissue; leukaemia arises from bone marrow

Carcinoma arises from epithelial tissue; leukaemia arises from the immune system

3.

MULTIPLE SELECT QUESTION

45 sec • 1 pt

Which of the following statement(s) on Clinical Trials in Oncology is true?

Phase III is to test the efficacy and identify the optimal dose

1st goal of the Phase II trial is to test the response rate

Phase I trial is to identify the Dose Limiting Toxicity and Maximum Tolerated Dose

Phase I trial is to compare the test drug with the reference treatment

4.

MULTIPLE SELECT QUESTION

45 sec • 1 pt

Select the correct statement(s) on CTCAE and RECIST:

RECIST is a way to measure the response of tumor to treatment

CTCAE describes the severity of organ toxicity for patients receiving cancer therapy

RECIST has 5 response criteria

CTCAE has 4 grading levels

5.

MULTIPLE SELECT QUESTION

45 sec • 1 pt

Which of the following(s) is/are used to definitely diagnose cancer?

Blood test

CT/MRI scan

PET scan

Microscopic analysis

6.

MULTIPLE SELECT QUESTION

45 sec • 1 pt

The tumour staging is focused on:

The tumour location & its size

Cancer’s tissue characteristics

Cellular characteristics of cancer

The investigations performed

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Mrs X, a 73-year-old female with a past medical history of congestive heart failure, chronic kidney disease, diabetes mellitus type II, and hypertension. She is capable of limited self-care and spends more than 50% of her walking hours confined to either a bed or chair. What is her ECOG status?

1

2

3

4

Create a free account and access millions of resources

Create resources
Host any resource
Get auto-graded reports
or continue with
Microsoft
Apple
Others
By signing up, you agree to our Terms of Service & Privacy Policy
Already have an account?